(Q73844809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Murine experimental autoimmune encephalomyelitis: a model of immune-mediated inflammation and multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

experimental autoimmune encephalomyelitis

7 November 2019

main subject

0 references

1 reference

A R Glabinski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Tani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

V K Tuohy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R M Ransohoff

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

number of pages

9

1 reference

inferred from page(s)

published in

Methods in Enzymology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

182-190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

The Effects of the Injection of Normal Brain Emulsion into Rabbits, with Special Reference to the Aetiology of the Paralytic Accidents of Antirabic Treatment

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Epidemiology of multiple sclerosis: a critical overview.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

A population-based study of multiple sclerosis in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

SPONTANEOUS ENCEPHALOMYELITIS OF MICE, A NEW VIRUS DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Animal models of demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Observations on remyelination in the rabbit spinal cord following demyelination induced by lysolecithin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Inheritance of susceptibility to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Self-determinants in autoimmune demyelinating disease: changes in T- cell response specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2897%2988015-9

7 January 2021

10.1016/S0076-6879(97)88015-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9356995%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference